Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / NYLI US LC R&D L
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
203K
-
Shares change
-
-3.46K
-
Total reported value, excl. options
-
$8.08M
-
Value change
-
-$137K
-
Number of sells
-
-4
-
Price
-
$39.79
Significant Holders of NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) as of Q3 2025
5 filings reported holding LRND - NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L as of Q3 2025.
NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 203K shares
.
Largest 5 shareholders include NEW YORK LIFE INVESTMENT MANAGEMENT LLC (190K shares), GTS SECURITIES LLC (13.1K shares), UBS Group AG (0 shares), MORGAN STANLEY (0 shares), and OSAIC HOLDINGS, INC. (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.